摘要来源: 药物devel ther。 2018; 12:2431-2442。 EPUB 2018 8月6日。PMID: 30122901“> 30122901 Tian, Dawei Zou, Yimin Shi, Nan Zhang Xiaolei Wang Background: Podocyte dedifferentiation and mesangial cell (MC) activation play an important role in many glomerular diseases associated with fibrosis. microRNA-21(miR-21)与肾纤维化密切相关,但未知miR-21是否以及如何促进podocyte de分化和MC激活以及黄色盐IV(AS-IV)是否通过调节miR-21来改善肾功能和纤维化。 材料和方法: Conclusion: Our results indicated that AS-IV ameliorates renal function and renal fibrosis by inhibiting miR-21 overexpression-induced podocyte dedifferentiation and MC activation in diabetic 肾脏疾病。这些发现为未来研究AS-IV作为肾小球疾病管理的潜在治疗剂的方法铺平了道路。